Results 121 to 130 of about 599,459 (163)
Some of the next articles are maybe not open access.

Lipoprotein (a)

European Journal of Cardiovascular Prevention & Rehabilitation, 1994
Our understanding of the pathophysiological role of lipoprotein (a) in cardiovascular disease and its clinical importance has improved, but there are still gaps in our knowledge and analytical performance that hinder the appropriate management of patients.
openaire   +2 more sources

β-lipoprotein, lipoprotein lipase and atromid

Journal of Atherosclerosis Research, 1963
Summary The lipoprotein lipase activity eluted in connection with chromatographically separated β-lipoprotein was considerably lower in 6 cases of essential hyperlipaemia than the average for 7 healthy controls. Atromid administration seemed to increase the lipoprotein lipase activity per mg β-lipoprotein protein in 4 of 5 cases.
P. Bedding, B. Hood, B. Carlander
openaire   +3 more sources

Lipoprotein(a) : new insights into an atherogenic lipoprotein

The Clinical Investigator, 1994
Lipoprotein(a) constitutes a macromolecular complex in human plasma that combines structural features from the blood clotting and the lipoprotein systems. Aside from the discovery of lipoprotein(a) [Lp(a)] as a potential independent risk factor for premature cardiovascular disease its physiological role and activity remains obscure.
Bartens, Werner, Wanner, Christoph
openaire   +3 more sources

Lipoprotein(a) and atherogenesis

Trends in Cardiovascular Medicine, 1994
Lipoprotein(a) is a major inherited risk factor for atherosclerosis. Many of its activities depend on its plasminlike component, apolipoprotein(a). In vitro studies suggest that apolipoprotein(a) could enhance lipid deposition through binding to sites in the vessel wall, interfere with fibrinolysis, and modulate smooth muscle cell activity.
Richard M. Lawn, Alexander C. Liu
openaire   +3 more sources

Lipoproteins in neonates

The Journal of Pediatrics, 1974
D E S P t T E T H E F A C T that hyperlipoproteinemia has received great clinical attention, there is a scarcity of information on the normal distribution of lipids and lipoproteins or screening tests for reliable detection of hyperlipoproteinemia in children.
Hertha R. Cress   +3 more
openaire   +3 more sources

High density lipoprotein and lipoprotein oxidation

Current Opinion in Lipidology, 1996
HDL protects LDL from oxidative damage known to contribute to the onset and progression of atherosclerosis. This antioxidant protection by HDL is mediated by intrinsic hydrolytic enzyme systems, by accelerated selective uptake of lipid peroxides from HDL and by antioxidant molecules.
openaire   +3 more sources

Lipoprotein(a) apheresis

Current Opinion in Lipidology, 2016
Purpose of review Currently, different methods for extracorporeal elimination of atherogenic apolipoprotein B100 containing lipoprotein particles are used in clinical practice. Most of them effectively remove both lipoprotein(a) [Lp(a)] and LDL.
Olga I. Afanasieva   +2 more
openaire   +2 more sources

Lipoproteins and coagulation

Perfusion, 1997
A broad range of molecular and cellular interactions contribute to various pathophysiological alterations in haemostasis. Recent studies have shown strong links between lipoproteins and coagulation factors. Findings suggest that lipoproteins play an important role in the fibrinolytic and thrombogenic mechanisms that influence the risks of patients in ...
Annette Basile-Borgia, John H. Abel
openaire   +3 more sources

The Plasma Lipoproteins

1977
Publisher Summary Plasma lipoproteins are the macromolecular complexes with reproducible lipid-protein ratios and stability in aqueous solutions. This chapter describes the classification of the plasma lipoproteins, molecular properties of apolipoproteins, molecular organization of lipoprotein particles, and lipoprotein metabolism.
Brewer Hb, James C. Osborne
openaire   +3 more sources

Glucagon and lipoproteins

Metabolism, 1976
HE HEPATIC PRODUCTION of lipoprotein is a complex phenomenon, involving a synchronous relationship between hepatic apoprotein synthesis, and the actual tipoprotein secretory event. A role for glucagon in modulating these events has been proposed.~ The administration of exogenous glucagon results in a pronounced hypolipemic response in man, dog, fowl ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy